Blumenauer, stakeholders elevate push for USMCA biologics changes

Rep. Earl Blumenauer (D-OR) is striving to graft biologics language included in the Trans-Pacific Partnership onto the U.S.-Mexico-Canada Agreement after it was “ignored” by the Office of U.S. Trade Representative over the objections of Canada and Mexico, he said on Friday. “TPP is slightly different in terms of what happened with access to medicines; that was an area that I was working on until the last gasp of TPP to try and change it,” Blumenauer said during a May 10...